These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25374433)

  • 1. Importance of follow-up cerebrospinal fluid analysis in cryptococcal meningoencephalitis.
    Skripuletz T; Schwenkenbecher P; Pars K; Stoll M; Conzen J; Bolat S; Pul R; Vonberg RP; Sedlacek L; Wurster U; Stangel M; Trebst C
    Dis Markers; 2014; 2014():162576. PubMed ID: 25374433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of antifungal drug levels in cerebrospinal fluid for cryptococcal meningoencephalitis.
    Shoji H; Takuma T; Ohbayashi H; Yoshida K; Yamamoto T; Niki Y
    J Infect Chemother; 2012 Oct; 18(5):775-9. PubMed ID: 22318291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of hospital discharge outcome from changes in cerebrospinal fluid/serum albumin quotient and cerebrospinal fluid lactate dehydrogenase in patients with cryptococcal meningitis.
    Huang Y; Zou J; Zhang KM; Li H; Hu DY; Liao WQ; Zhang L; Pan WH
    Future Microbiol; 2022 Mar; 17():223-233. PubMed ID: 34905957
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cryptococcal meningitis in children: description of 3 cases].
    Ndiaye M; Diagne NR; Seck LB; Sow AD; Sène MS; Diop AG; Sow HD; Ndiaye MM
    Med Trop (Mars); 2011 Apr; 71(2):176-8. PubMed ID: 21695878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic factors of cryptococcal meningitis in HIV-negative patients.
    Lu CH; Chang WN; Chang HW; Chuang YC
    J Hosp Infect; 1999 Aug; 42(4):313-20. PubMed ID: 10467545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and outcomes of patients with cryptococcal meningoencephalitis in a resource-limited setting.
    Chayakulkeeree M; Wangchinda P
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S26-34. PubMed ID: 24772578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of cryptococcal meningoencephalitis with the cerebral superficial cystic lesions detected on magnetic resonance imagings].
    Kondo H; Yamamoto K; Kubo H; Hosino M; Okayama K
    Rinsho Shinkeigaku; 1995 Apr; 35(4):373-8. PubMed ID: 7614762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. False negative diagnostic errors with polymerase chain reaction for the detection of cryptococcal meningoencephalitis.
    Lewis PO; Lanier CG; Patel PD; Krolikowski WD; Krolikowski MA
    Med Mycol; 2020 Apr; 58(3):408-410. PubMed ID: 31212317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptococcal meningoencephalitis in an elderly immunocompetent non-HIV-infected patient.
    Vandroz E; Froidure M; Sifaoui F; Legout L
    Med Mal Infect; 2019 Feb; 49(1):75-76. PubMed ID: 30472030
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood-CSF-barrier dysfunction is a marker for encephalitic involvement in patients with aseptic meningitis/meningoencephalitis.
    Hoyer C; Eisele P; Ebert AD; Schneider S; Gass A; Fatar M; Szabo K; Alonso A
    J Clin Virol; 2016 Nov; 84():82-86. PubMed ID: 27736668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison between CSF samples from AIDS and non AIDS patients with neurocryptococcosis].
    dos Reis-Filho JB; Matas SL; Fischman O; Morales BC; Juliano Y
    Rev Inst Med Trop Sao Paulo; 1994; 36(3):225-30. PubMed ID: 7855486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis.
    Liao CH; Chi CY; Wang YJ; Tseng SW; Chou CH; Ho CM; Lin PC; Ho MW; Wang JH
    J Microbiol Immunol Infect; 2012 Aug; 45(4):296-304. PubMed ID: 22608531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B.
    Pitisuttithum P; Tansuphasawadikul S; Simpson AJ; Howe PA; White NJ
    J Infect; 2001 Nov; 43(4):226-33. PubMed ID: 11869059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early mycological treatment failure in AIDS-associated cryptococcal meningitis.
    Robinson PA; Bauer M; Leal MA; Evans SG; Holtom PD; Diamond DA; Leedom JM; Larsen RA
    Clin Infect Dis; 1999 Jan; 28(1):82-92. PubMed ID: 10028076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients.
    Anekthananon T; Manosuthi W; Chetchotisakd P; Kiertiburanakul S; Supparatpinyo K; Ratanasuwan W; Pappas PG; Filler SG; Kopetskie HA; Nolen TL; Kendrick AS; Larsen RA;
    Int J STD AIDS; 2011 Nov; 22(11):665-70. PubMed ID: 22096053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Itraconazole in the treatment of cryptococcal meningitis.
    Chotmongkol V; Jitpimolmard S
    J Med Assoc Thai; 1992 Feb; 75(2):85-8. PubMed ID: 1322948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid CXCL13 is a prognostic marker for aseptic meningitis.
    Fujimori J; Nakashima I; Kuroda H; Fujihara K; Aoki M
    J Neuroimmunol; 2014 Aug; 273(1-2):77-84. PubMed ID: 24907903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal therapy for treatment of cryptococcal meningitis.
    Yao Z; Liao W; Wen H
    Chin Med J (Engl); 2000 Feb; 113(2):178-80. PubMed ID: 11775548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcal meningitis in two apparently immunocompetent Maltese patients.
    Zahra LV; Azzopardi CM; Scott G
    Mycoses; 2004 Apr; 47(3-4):168-73. PubMed ID: 15078436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
    Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
    J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.